First Case Report of Peritoneal Dialysis-associated Peritonitis Caused by Lysinibacillus sphaericus

Intern Med. 2023 Oct 1;62(19):2919-2922. doi: 10.2169/internalmedicine.1141-22. Epub 2023 Feb 22.

Abstract

We herein report a case of peritoneal dialysis-associated peritonitis caused by Lysinibacillus sphaericus in a 40s-year-old patient. Treatment was initiated with intermittent intraperitoneal cefazolin and ceftazidime. Later, both peritoneal dialysate and blood cultures detected L. sphaericus, so the antibiotic was changed to ampicillin (ABPC). The patient was treated with a combination of intraperitoneal intermittent and intravenous ABPC for 7 days, followed by 14 days of amoxicillin. The patient experienced no adverse events and no recurrence for 30 days. The patient had four dogs, and the infection was deemed likely to have been caused by environmental contamination and inadequate catheter replacement.

Keywords: Lysinibacillus sphaericus; peritoneal dialysis; peritonitis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Ampicillin
  • Anti-Bacterial Agents* / therapeutic use
  • Humans
  • Peritoneal Dialysis* / adverse effects
  • Peritoneal Dialysis, Continuous Ambulatory* / adverse effects
  • Peritonitis* / drug therapy
  • Peritonitis* / etiology

Substances

  • Ampicillin
  • Anti-Bacterial Agents

Supplementary concepts

  • Lysinibacillus sphaericus